-
1
-
-
72249087115
-
International study of the prevalence and outcomes of infection in intensive care units
-
Vincent JL, Rello J, Marshall J, et al. International study of the prevalence and outcomes of infection in intensive care units. JAMA. 2009; 302(21):2323–2329.
-
(2009)
JAMA
, vol.302
, Issue.21
, pp. 2323-2329
-
-
Vincent, J.L.1
Rello, J.2
Marshall, J.3
-
2
-
-
84865976141
-
Update on bloodstream infections in ICUs
-
Timsit JF, Laupland KB. Update on bloodstream infections in ICUs. Curr Opin Crit Care. 2012;18(5):479–486.
-
(2012)
Curr Opin Crit Care
, vol.18
, Issue.5
, pp. 479-486
-
-
Timsit, J.F.1
Laupland, K.B.2
-
3
-
-
84874781751
-
Secular trends in nosocomial bloodstream infections: Antibiotic-resistant bacteria increase the total burden of infection
-
Ammerlaan H, Harbarth S, Buiting A, et al. Secular trends in nosocomial bloodstream infections: antibiotic-resistant bacteria increase the total burden of infection. Clinical Infect Dis. 2013;56(6):798–805.
-
(2013)
Clinical Infect Dis
, vol.56
, Issue.6
, pp. 798-805
-
-
Ammerlaan, H.1
Harbarth, S.2
Buiting, A.3
-
4
-
-
84857646835
-
Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance
-
Magiorakos AP, Srinivasan A, Carey R, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281.
-
(2012)
Clin Microbiol Infect
, vol.18
, Issue.3
, pp. 268-281
-
-
Magiorakos, A.P.1
Srinivasan, A.2
Carey, R.3
-
5
-
-
79960743378
-
Society’s failure to protect a precious resource: Antibiotics
-
Carlet J, Collignon P, Goldmann D, et al. Society’s failure to protect a precious resource: antibiotics. Lancet. 2011;378(9788):369–371.
-
(2011)
Lancet
, vol.378
, Issue.9788
, pp. 369-371
-
-
Carlet, J.1
Collignon, P.2
Goldmann, D.3
-
6
-
-
84455173002
-
Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis
-
Retamar P, Portillo MM, López-Prieto MD, et al. Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: a propensity score-based analysis. Antimicrob Agents Chemother. 2012;56(1):472–478.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, Issue.1
, pp. 472-478
-
-
Retamar, P.1
Portillo, M.M.2
López-Prieto, M.D.3
-
7
-
-
81255171675
-
Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment
-
Zarkotou O, Pournaras S, Tselioti P, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011;17(12):1798–1803.
-
(2011)
Clin Microbiol Infect
, vol.17
, Issue.12
, pp. 1798-1803
-
-
Zarkotou, O.1
Pournaras, S.2
Tselioti, P.3
-
8
-
-
12944295224
-
Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: Risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome
-
Kang CI, Kim SH, Park WB, et al. Bloodstream infections caused by antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760–766.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, Issue.2
, pp. 760-766
-
-
Kang, C.I.1
Kim, S.H.2
Park, W.B.3
-
9
-
-
77954977077
-
Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit
-
Jung JY, Park MS, Kim SE, et al. Risk factors for multi-drug resistant Acinetobacter baumannii bacteremia in patients with colonization in the intensive care unit. BMC Infect Dis. 2010;10:228.
-
(2010)
BMC Infect Dis
, vol.10
, pp. 228
-
-
Jung, J.Y.1
Park, M.S.2
Kim, S.E.3
-
10
-
-
84872086922
-
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: The EUROBACT International Cohort Study
-
Tabah A, Koulenti D, Laupland K, et al. Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study. Intensive Care Med. 2012;38(12):1930–1945.
-
(2012)
Intensive Care Med
, vol.38
, Issue.12
, pp. 1930-1945
-
-
Tabah, A.1
Koulenti, D.2
Laupland, K.3
-
11
-
-
77954234071
-
Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals
-
Rodríguez-Baño J, López-Prieto MD, Portillo MM, et al. Epidemiology and clinical features of community-acquired, healthcare-associated and nosocomial bloodstream infections in tertiary-care and community hospitals. Clin Microbiol Infect. 2010;16(9):1408–1413.
-
(2010)
Clin Microbiol Infect
, vol.16
, Issue.9
, pp. 1408-1413
-
-
Rodríguez-Baño, J.1
López-Prieto, M.D.2
Portillo, M.M.3
-
12
-
-
79551588564
-
Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study
-
Kollef MH, Zilberberg MD, Shorr AF, et al. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: a multicenter cohort study. J Infect. 2011;62(2):130–135.
-
(2011)
J Infect
, vol.62
, Issue.2
, pp. 130-135
-
-
Kollef, M.H.1
Zilberberg, M.D.2
Shorr, A.F.3
-
13
-
-
79953746894
-
Health-care-associated bloodstream infections at admission to the ICU
-
Vallés J, Alvarez-Lerma F, Palomar M, et al. Health-care-associated bloodstream infections at admission to the ICU. Chest. 2011;139(4): 810–815.
-
(2011)
Chest
, vol.139
, Issue.4
, pp. 810-815
-
-
Vallés, J.1
Alvarez-Lerma, F.2
Palomar, M.3
-
14
-
-
13444278539
-
Risk factors for ineffective therapy in patients with bloodstream infection
-
McDonald JR, Friedman ND, Stout JE, Sexton DJ, Kaye KS. Risk factors for ineffective therapy in patients with bloodstream infection. Arch Intern Med. 2005;165(3):308–313.
-
(2005)
Arch Intern Med
, vol.165
, Issue.3
, pp. 308-313
-
-
McDonald, J.R.1
Friedman, N.D.2
Stout, J.E.3
Sexton, D.J.4
Kaye, K.S.5
-
16
-
-
0034913951
-
Dissemination of antibiotic-resistant bacteria across geographic borders
-
Okeke IN, Edelman R. Dissemination of antibiotic-resistant bacteria across geographic borders. Clin Infect Dis. 2001;33(3):364–369.
-
(2001)
Clin Infect Dis
, vol.33
, Issue.3
, pp. 364-369
-
-
Okeke, I.N.1
Edelman, R.2
-
17
-
-
24744454608
-
Widespread transfer of resistance genes between bacterial species in an intensive care unit: Implications for hospital epidemiology
-
Al Naiemi N, Duim B, Savelkoul PH, et al. Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol. 2005;43(9):4862–4864.
-
(2005)
J Clin Microbiol
, vol.43
, Issue.9
, pp. 4862-4864
-
-
Al Naiemi, N.1
Duim, B.2
Savelkoul, P.H.3
-
18
-
-
0031021303
-
The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus
-
Ayliffe G. The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 1997;24 Suppl 1: S74–S79.
-
(1997)
Clin Infect Dis
, vol.24
, pp. S74-S79
-
-
Ayliffe, G.1
-
19
-
-
84928262926
-
Combatting resistance in intensive care: The multimodal approach of the Spanish ICU “Zero Resistance” program
-
Montero JG, Lerma FÁ, Galleymore PR, et al. Combatting resistance in intensive care: the multimodal approach of the Spanish ICU “Zero Resistance” program. Crit Care. 2015;19:114.
-
(2015)
Crit Care
, vol.19
, pp. 114
-
-
Montero, J.G.1
Lerma, F.2
Galleymore, P.R.3
-
20
-
-
84939814301
-
Use of Cepheid Xpert Carba-R® for rapid detection of carbapenemase-producing bacteria in critically ill, abdominal surgical patients: First report of an observational study
-
Cortegiani A, Russotto V, Capuano P, et al. Use of Cepheid Xpert Carba-R® for rapid detection of carbapenemase-producing bacteria in critically ill, abdominal surgical patients: first report of an observational study. Crit Care. 2015;19 Suppl 1:108.
-
(2015)
Crit Care
, vol.19
, pp. 108
-
-
Cortegiani, A.1
Russotto, V.2
Capuano, P.3
-
21
-
-
33845880922
-
An intervention to decrease catheter-related bloodstream infections in the ICU
-
Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–2732.
-
(2006)
N Engl J Med
, vol.355
, Issue.26
, pp. 2725-2732
-
-
Pronovost, P.1
Needham, D.2
Berenholtz, S.3
-
22
-
-
5644300386
-
Eliminating catheter-related bloodstream infections in the intensive care unit
-
Berenholtz SM, Pronovost PJ, Lipsett PA, et al. Eliminating catheter-related bloodstream infections in the intensive care unit. Crit Care Med. 2004;32(10):2014–2020.
-
(2004)
Crit Care Med
, vol.32
, Issue.10
, pp. 2014-2020
-
-
Berenholtz, S.M.1
Pronovost, P.J.2
Lipsett, P.A.3
-
23
-
-
0030095189
-
The role of understaffing in central venous catheter-associated bloodstream infection
-
Fridkin SK, Pear SM, Williamson TH, Galgiani JN, Jarvis WR. The role of understaffing in central venous catheter-associated bloodstream infection. Infect Control Hosp Epidemiol. 1996;17(3):150–158.
-
(1996)
Infect Control Hosp Epidemiol
, vol.17
, Issue.3
, pp. 150-158
-
-
Fridkin, S.K.1
Pear, S.M.2
Williamson, T.H.3
Galgiani, J.N.4
Jarvis, W.R.5
-
24
-
-
67651091946
-
Infection with panresistant Klebsiella pneumoniae: A report of 2 cases and a brief review of the literature
-
Elemam A, Rahimian J, Mandell W. Infection with panresistant Klebsiella pneumoniae: a report of 2 cases and a brief review of the literature. Clin Infect Dis. 2009;49(2):271–274.
-
(2009)
Clin Infect Dis
, vol.49
, Issue.2
, pp. 271-274
-
-
Elemam, A.1
Rahimian, J.2
Mandell, W.3
-
25
-
-
83655201460
-
Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
-
Ben-David D, Kordevani R, Keller N, et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect. 2012;18(1):54–60.
-
(2012)
Clin Microbiol Infect
, vol.18
, Issue.1
, pp. 54-60
-
-
Ben-David, D.1
Kordevani, R.2
Keller, N.3
-
26
-
-
79961026033
-
Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis
-
Johnson MT, Reichley R, Hoppe-Bauer J, Dunne WM, Micek S, Kollef M. Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis. Crit Care Med. 2011;39(8):1859–1865.
-
(2011)
Crit Care Med
, vol.39
, Issue.8
, pp. 1859-1865
-
-
Johnson, M.T.1
Reichley, R.2
Hoppe-Bauer, J.3
Dunne, W.M.4
Micek, S.5
Kollef, M.6
-
27
-
-
71949096445
-
Between community and hospital: Healthcare-associated Gram-negative bacteremia among hospitalized patients
-
Marschall J, Fraser VJ, Doherty J, Warren DK. Between community and hospital: healthcare-associated Gram-negative bacteremia among hospitalized patients. Infect Control Hosp Epidemiol. 2009;30(11): 1050–1056.
-
(2009)
Infect Control Hosp Epidemiol
, vol.30
, Issue.11
, pp. 1050-1056
-
-
Marschall, J.1
Fraser, V.J.2
Doherty, J.3
Warren, D.K.4
-
28
-
-
48649109976
-
Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: A case-control study
-
Shih MJ, Lee NY, Lee HC, et al. Risk factors of multidrug resistance in nosocomial bacteremia due to Acinetobacter baumannii: a case-control study. J Microbiol Immunol Infect. 2008;41(2):118–123.
-
(2008)
J Microbiol Immunol Infect
, vol.41
, Issue.2
, pp. 118-123
-
-
Shih, M.J.1
Lee, N.Y.2
Lee, H.C.3
-
29
-
-
69749084388
-
Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: A case-control study
-
Jang TN, Lee SH, Huang CH, Lee CL, Chen WY. Risk factors and impact of nosocomial Acinetobacter baumannii bloodstream infections in the adult intensive care unit: a case-control study. J Hosp Infect. 2009;73(2):143–150.
-
(2009)
J Hosp Infect
, vol.73
, Issue.2
, pp. 143-150
-
-
Jang, T.N.1
Lee, S.H.2
Huang, C.H.3
Lee, C.L.4
Chen, W.Y.5
-
30
-
-
0031940776
-
Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy
-
Thomas JK, Forrest A, Bhavnani SM, et al. Pharmacodynamic evaluation of factors associated with the development of bacterial resistance in acutely ill patients during therapy. Antimicrob Agents Chemother. 1998;42(3):521–527.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, Issue.3
, pp. 521-527
-
-
Thomas, J.K.1
Forrest, A.2
Bhavnani, S.M.3
-
31
-
-
84869835694
-
Antibiotic resistance mechanisms in the intensive care unit
-
Hatcher J, Dhillon R, Azadian BS. Antibiotic resistance mechanisms in the intensive care unit. J Intensive Care Soc. 2012;13(4):297–303.
-
(2012)
J Intensive Care Soc
, vol.13
, Issue.4
, pp. 297-303
-
-
Hatcher, J.1
Dhillon, R.2
Azadian, B.S.3
-
32
-
-
84987804431
-
Mechanisms of polymyxin resistance: Acquired and intrinsic resistance in bacteria
-
Olaitan AO, Morand S, Rolain JM. Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria. Front Microbiol. 2014;5:643.
-
(2014)
Front Microbiol
, vol.5
, pp. 643
-
-
Olaitan, A.O.1
Morand, S.2
Rolain, J.M.3
-
33
-
-
0036498656
-
Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: Our worst nightmare?
-
Livermore DM. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Clin Infect Dis. 2002; 34(5):634–640.
-
(2002)
Clin Infect Dis
, vol.34
, Issue.5
, pp. 634-640
-
-
Livermore, D.M.1
-
34
-
-
0023837814
-
Vancomycin-resistant enterococci
-
Uttley AC, Collins C, Naidoo J, George R. Vancomycin-resistant enterococci. Lancet. 1988;331(8575):57–58.
-
(1988)
Lancet
, vol.331
, Issue.8575
, pp. 57-58
-
-
Uttley, A.C.1
Collins, C.2
Naidoo, J.3
George, R.4
-
35
-
-
0033983232
-
Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates
-
Elsner HA, Sobottka I, Mack D, Laufs R, Claussen M, Wirth R. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates. Eur J Clin Microbiol Infect Dis. 2000;19(1):39–42.
-
(2000)
Eur J Clin Microbiol Infect Dis
, vol.19
, Issue.1
, pp. 39-42
-
-
Elsner, H.A.1
Sobottka, I.2
Mack, D.3
Laufs, R.4
Claussen, M.5
Wirth, R.6
-
36
-
-
55249117030
-
Emergence and management of drug-resistant enterococcal infections
-
Arias C, Murray B. Emergence and management of drug-resistant enterococcal infections. Expert Rev Anti Infect Ther. 2008;6(5):637–655.
-
(2008)
Expert Rev Anti Infect Ther
, vol.6
, Issue.5
, pp. 637-655
-
-
Arias, C.1
Murray, B.2
-
37
-
-
84868294096
-
Intrinsic and acquired resistance mechanisms in enterococcus
-
Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3(5):421–433.
-
(2012)
Virulence
, vol.3
, Issue.5
, pp. 421-433
-
-
Hollenbeck, B.L.1
Rice, L.B.2
-
38
-
-
0037071849
-
Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis
-
Shankar N, Baghdayan AS, Gilmore MS. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature. 2002;417(6890):746–750.
-
(2002)
Nature
, vol.417
, Issue.6890
, pp. 746-750
-
-
Shankar, N.1
Baghdayan, A.S.2
Gilmore, M.S.3
-
39
-
-
33846814920
-
Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation
-
Van Wamel WJ, Hendrickx AP, Bonten MJ, Top J, Posthuma G, Willems RJ. Growth condition-dependent Esp expression by Enterococcus faecium affects initial adherence and biofilm formation. Infect Immun. 2007;75(2):924–931.
-
(2007)
Infect Immun
, vol.75
, Issue.2
, pp. 924-931
-
-
Van Wamel, W.J.1
Hendrickx, A.P.2
Bonten, M.J.3
Top, J.4
Posthuma, G.5
Willems, R.J.6
-
40
-
-
63249115842
-
Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci
-
Leclercq R. Epidemiological and resistance issues in multidrug-resistant staphylococci and enterococci. Clin Microbiol Infect. 2009;15(3): 224–2231.
-
(2009)
Clin Microbiol Infect
, vol.15
, Issue.3
, pp. 224-2231
-
-
Leclercq, R.1
-
41
-
-
0032551901
-
Staphylococcus aureus infections
-
Lowy F. Staphylococcus aureus infections. N Engl J Med. 1998;339(8): 520–532.
-
(1998)
N Engl J Med
, vol.339
, Issue.8
, pp. 520-532
-
-
Lowy, F.1
-
42
-
-
69249083586
-
Waves of resistance: Staphylococcus aureus in the antibiotic era
-
Chambers HF, DeLeo FR. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat Re Microbiol. 2009;7(9):629–641.
-
(2009)
Nat Re Microbiol
, vol.7
, Issue.9
, pp. 629-641
-
-
Chambers, H.F.1
Deleo, F.R.2
-
43
-
-
0033591467
-
Bacterial biofilms: A common cause of persistent infections
-
Costerton J, Stewart PS, Greenberg E. Bacterial biofilms: a common cause of persistent infections. Science. 1999;284(5418):1318–1322.
-
(1999)
Science
, vol.284
, Issue.5418
, pp. 1318-1322
-
-
Costerton, J.1
Stewart, P.S.2
Greenberg, E.3
-
44
-
-
0034038098
-
New class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus
-
Katayama Y, Ito T, Hiramatsu K. A new class of genetic element, Staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother. 2000;44(6):1549–1555.
-
(2000)
Antimicrob Agents Chemother
, vol.44
, Issue.6
, pp. 1549-1555
-
-
Katayama, Y.1
Ito, T.2
Hiramatsu, K.A.3
-
45
-
-
0021810288
-
Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus
-
Utsui Y, Yokota T. Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus. Antimicrob Agents Chemother. 1985;28(3):397–403.
-
(1985)
Antimicrob Agents Chemother
, vol.28
, Issue.3
, pp. 397-403
-
-
Utsui, Y.1
Yokota, T.2
-
46
-
-
84901687359
-
Tst1-Positive ST22-MRSA-IVa in healthy Italian preschool children
-
Geraci D, Bonura C, Giuffrè M, et al. tst1-Positive ST22-MRSA-IVa in healthy Italian preschool children. Infection. 2014;42(3):535–538.
-
(2014)
Infection
, vol.42
, Issue.3
, pp. 535-538
-
-
Geraci, D.1
Bonura, C.2
Giuffrè, M.3
-
47
-
-
71549136472
-
Molecular epidemiology and risk factors for nasal carriage of Staphylococcus aureus and methicillin-resistant S. Aureus in infants attending day care centers in Brazil
-
Lamaro-Cardoso J, de Lencastre H, Kipnis A, et al. Molecular epidemiology and risk factors for nasal carriage of Staphylococcus aureus and methicillin-resistant S. aureus in infants attending day care centers in Brazil. J Clin Microbiol. 2009;47(12):3991–3997.
-
(2009)
J Clin Microbiol
, vol.47
, Issue.12
, pp. 3991-3997
-
-
Lamaro-Cardoso, J.1
De Lencastre, H.2
Kipnis, A.3
-
48
-
-
34848852230
-
Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA)
-
Appelbaum PC. Reduced glycopeptide susceptibility in methicillin-resistant Staphylococcus aureus (MRSA). Int J Antimicrob Agents. 2007;30(5):398–408.
-
(2007)
Int J Antimicrob Agents
, vol.30
, Issue.5
, pp. 398-408
-
-
Appelbaum, P.C.1
-
49
-
-
33646837531
-
Resistance in gram-negative bacteria: Enterobacteriaceae
-
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med. 2006;119(6 Suppl 1):S20–S28.
-
(2006)
Am J Med
, vol.119
, Issue.6
, pp. S20-S28
-
-
Paterson, D.L.1
-
50
-
-
39049128343
-
Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern
-
Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159–166.
-
(2008)
Lancet Infect Dis
, vol.8
, Issue.3
, pp. 159-166
-
-
Pitout, J.D.1
Laupland, K.B.2
-
51
-
-
67749114471
-
Emergence of high levels of extended-spectrum-β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: Data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007
-
Hawser SP, Bouchillon SK, Hoban DJ, Badal RE, Hsueh PR, Paterson DL. Emergence of high levels of extended-spectrum-β-lactamase-producing Gram-negative bacilli in the Asia-Pacific region: data from the Study for Monitoring Antimicrobial Resistance Trends (SMART) program, 2007. Antimicrob Agents Chemother. 2009;53(8):3280–3284.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, Issue.8
, pp. 3280-3284
-
-
Hawser, S.P.1
Bouchillon, S.K.2
Hoban, D.J.3
Badal, R.E.4
Hsueh, P.R.5
Paterson, D.L.6
-
52
-
-
0029071785
-
A functional classification scheme for beta-lactamases and its correlation with molecular structure
-
Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39(6):1211–1233.
-
(1995)
Antimicrob Agents Chemother
, vol.39
, Issue.6
, pp. 1211-1233
-
-
Bush, K.1
Jacoby, G.A.2
Medeiros, A.A.3
-
53
-
-
21244488243
-
Revised Ambler classification of β-lactamases
-
Hall BG, Barlow M. Revised Ambler classification of β-lactamases. J Antimicrob Chemother. 2005;55(6):1050–1051.
-
(2005)
J Antimicrob Chemother
, vol.55
, Issue.6
, pp. 1050-1051
-
-
Hall, B.G.1
Barlow, M.2
-
54
-
-
84866072596
-
Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae: Importance of combination therapy
-
Tumbarello M, Viale P, Viscoli C, et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis. 2012;55(7):943–950.
-
(2012)
Clin Infect Dis
, vol.55
, Issue.7
, pp. 943-950
-
-
Tumbarello, M.1
Viale, P.2
Viscoli, C.3
-
55
-
-
62749195559
-
The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria
-
Nordmann P, Cuzon G, Naas T. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria. Lancet Infect Dis. 2009;9(4): 228–236.
-
(2009)
Lancet Infect Dis
, vol.9
, Issue.4
, pp. 228-236
-
-
Nordmann, P.1
Cuzon, G.2
Naas, T.3
-
56
-
-
50149087907
-
Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon
-
Matar G, Cuzon G, Araj G, et al. Oxacillinase-mediated resistance to carbapenems in Klebsiella pneumoniae from Lebanon. Clin Microbiol Infect. 2008;14(9):887–888.
-
(2008)
Clin Microbiol Infect
, vol.14
, Issue.9
, pp. 887-888
-
-
Matar, G.1
Cuzon, G.2
Araj, G.3
-
57
-
-
50949083806
-
Plasmid-encoded carbapenem-hydrolyzing β-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium
-
Cuzon G, Naas T, Bogaerts P, Glupczynski Y, Huang TD, Nordmann P. Plasmid-encoded carbapenem-hydrolyzing β-lactamase OXA-48 in an imipenem-susceptible Klebsiella pneumoniae strain from Belgium. Antimicrob Agents Chemother. 2008;52(9):3463–3464.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, Issue.9
, pp. 3463-3464
-
-
Cuzon, G.1
Naas, T.2
Bogaerts, P.3
Glupczynski, Y.4
Huang, T.D.5
Nordmann, P.6
-
58
-
-
0035084032
-
Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
-
Yigit H, Queenan AM, Anderson GJ, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4): 1151–1161.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, Issue.4
, pp. 1151-1161
-
-
Yigit, H.1
Queenan, A.M.2
Erson, G.J.3
-
59
-
-
40549135623
-
High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression
-
Zhang R, Yang L, Cai JC, Zhou HW, Chen GX. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol. 2008;57(3):332–337.
-
(2008)
J Med Microbiol
, vol.57
, Issue.3
, pp. 332-337
-
-
Zhang, R.1
Yang, L.2
Cai, J.C.3
Zhou, H.W.4
Chen, G.X.5
-
60
-
-
0031792165
-
Klebsiella spp. As nosocomial pathogens: Epidemiology, taxonomy, typing methods, and pathogenicity factors
-
Podschun R, Ullmann U. Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin Microbiol Rev. 1998;11(4):589–603.
-
(1998)
Clin Microbiol Rev
, vol.11
, Issue.4
, pp. 589-603
-
-
Podschun, R.1
Ullmann, U.2
-
61
-
-
84876226990
-
Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems
-
Gutu AD, Sgambati N, Strasbourger P, et al. Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems. Antimicrob Agents Chemother. 2013;57(5):2204–2215.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, Issue.5
, pp. 2204-2215
-
-
Gutu, A.D.1
Sgambati, N.2
Strasbourger, P.3
-
62
-
-
80051877413
-
Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals
-
Mezzatesta M, Gona F, Caio C, et al. Outbreak of KPC-3-producing, and colistin-resistant, Klebsiella pneumoniae infections in two Sicilian hospitals. Clin Microbiol Infect. 2011;17(9):1444–1447.
-
(2011)
Clin Microbiol Infect
, vol.17
, Issue.9
, pp. 1444-1447
-
-
Mezzatesta, M.1
Gona, F.2
Caio, C.3
-
63
-
-
84866426325
-
Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011
-
Mammina C, Bonura C, Di Bernardo F, et al. Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011. Euro Surveill. 2012;17(33): 1–4.
-
(2012)
Euro Surveill
, vol.17
, Issue.33
, pp. 1-4
-
-
Mammina, C.1
Bonura, C.2
Di Bernardo, F.3
-
64
-
-
84898983354
-
Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae
-
Velkov T, Deris ZZ, Huang JX, et al. Surface changes and polymyxin interactions with a resistant strain of Klebsiella pneumoniae. Innate Immun. 2014;20(4):350–363.
-
(2014)
Innate Immun
, vol.20
, Issue.4
, pp. 350-363
-
-
Velkov, T.1
Deris, Z.Z.2
Huang, J.X.3
-
65
-
-
77955545870
-
Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43
-
Cheng HY, Chen YF, Peng HL. Molecular characterization of the PhoPQ-PmrD-PmrAB mediated pathway regulating polymyxin B resistance in Klebsiella pneumoniae CG43. J Biomed Sci. 2010;17:60.
-
(2010)
J Biomed Sci
, vol.17
, pp. 60
-
-
Cheng, H.Y.1
Chen, Y.F.2
Peng, H.L.3
-
66
-
-
84885909781
-
In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator
-
Cannatelli A, D’Andrea MM, Giani T, et al. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator. Antimicrob Agents Chemother. 2013;57(11):5521–5526.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, Issue.11
, pp. 5521-5526
-
-
Cannatelli, A.1
D’Andrea, M.M.2
Giani, T.3
-
67
-
-
84911918980
-
Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: An epidemiological and molecular study
-
Olaitan AO, Diene SM, Kempf M, et al. Worldwide emergence of colistin resistance in Klebsiella pneumoniae from healthy humans and patients in Lao PDR, Thailand, Israel, Nigeria and France owing to inactivation of the PhoP/PhoQ regulator mgrB: an epidemiological and molecular study. Int J Antimicrob Agents. 2014;44(6):500–507.
-
(2014)
Int J Antimicrob Agents
, vol.44
, Issue.6
, pp. 500-507
-
-
Olaitan, A.O.1
Diene, S.M.2
Kempf, M.3
-
68
-
-
83655169845
-
Antibacterial agents: Back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin?
-
Carlet J, Mainardi JL. Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin? Clin Microbiol Infect. 2012;18(1):1–3.
-
(2012)
Clin Microbiol Infect
, vol.18
, Issue.1
, pp. 1-3
-
-
Carlet, J.1
Mainardi, J.L.2
-
70
-
-
54349118690
-
Reynolds R. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001– 2006
-
Livermore DM, Hope R, Brick G, Lillie M, Reynolds R. Non-susceptibility trends among Enterobacteriaceae from bacteraemias in the UK and Ireland, 2001– 2006. J Antimicrob Chemother. 2008;62 Suppl 2:ii41–ii54.
-
(2008)
J Antimicrob Chemother
, vol.62
, pp. ii41-ii54
-
-
Livermore, D.M.1
Hope, R.2
Brick, G.3
Lillie, M.4
-
71
-
-
84874219168
-
Antibiotic resistance – why is the problem so difficult to solve?
-
Höjgård S. Antibiotic resistance – why is the problem so difficult to solve? Infect Ecol Epidemiol. 2012;2:18165.
-
(2012)
Infect Ecol Epidemiol
, vol.2
, pp. 18165
-
-
Höjgård, S.1
-
72
-
-
80051815004
-
First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain
-
Solé M, Pitart C, Roca I, et al. First description of an Escherichia coli strain producing NDM-1 carbapenemase in Spain. Antimicrob Agents Chemother. 2011;55(9):4402–4404.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, Issue.9
, pp. 4402-4404
-
-
Solé, M.1
Pitart, C.2
Roca, I.3
-
73
-
-
0029010091
-
Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A
-
Nummila K, Kilpeläinen I, Zähringer U, Vaara M, Helander IM. Lipopolysaccharides of polymyxin B-resistant mutants of Escherichia coli are extensively substituted by 2-aminoethyl pyrophosphate and contain aminoarabinose in lipid A. Mol Microbiol. 1995;16(2):271–278.
-
(1995)
Mol Microbiol
, vol.16
, Issue.2
, pp. 271-278
-
-
Nummila, K.1
Kilpeläinen, I.2
Zähringer, U.3
Vaara, M.4
Helander, I.M.5
-
74
-
-
8244233838
-
Enterobacter spp.: Pathogens poised to flourish at the turn of the century
-
Sanders W, Sanders CC. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev. 1997;10(2):220–241.
-
(1997)
Clin Microbiol Rev
, vol.10
, Issue.2
, pp. 220-241
-
-
Sanders, W.1
Sanders, C.C.2
-
75
-
-
84864341778
-
Enterobacter cloacae complex: Clinical impact and emerging antibiotic resistance
-
Mezzatesta ML, Gona F, Stefani S. Enterobacter cloacae complex: clinical impact and emerging antibiotic resistance. Future Microbiol. 2012;7(7):887–902.
-
(2012)
Future Microbiol
, vol.7
, Issue.7
, pp. 887-902
-
-
Mezzatesta, M.L.1
Gona, F.2
Stefani, S.3
-
76
-
-
33748681343
-
How long do nosocomial pathogens persist on inanimate surfaces? A systematic review
-
Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130.
-
(2006)
BMC Infect Dis
, vol.6
, pp. 130
-
-
Kramer, A.1
Schwebke, I.2
Kampf, G.3
-
77
-
-
34447556772
-
Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii
-
Vila J, Martí S, Sánchez-Céspedes J. Porins, efflux pumps and multidrug resistance in Acinetobacter baumannii. J Antimicrob Chemother. 2007;59(6):1210–1215.
-
(2007)
J Antimicrob Chemother
, vol.59
, Issue.6
, pp. 1210-1215
-
-
Vila, J.1
Martí, S.2
Sánchez-Céspedes, J.3
-
78
-
-
27544464928
-
Clinical impact and pathogenicity of Acinetobacter
-
Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005;11(11):868–873.
-
(2005)
Clin Microbiol Infect
, vol.11
, Issue.11
, pp. 868-873
-
-
Joly-Guillou, M.L.1
-
79
-
-
34547422759
-
Carbapenemases: The versatile β-lactamases
-
Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440–458.
-
(2007)
Clin Microbiol Rev
, vol.20
, Issue.3
, pp. 440-458
-
-
Queenan, A.M.1
Bush, K.2
-
80
-
-
33746585743
-
Carbapenem resistance in Acinetobacter baumannii: Mechanisms and epidemiology
-
Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect. 2006;12(9):826–836.
-
(2006)
Clin Microbiol Infect
, vol.12
, Issue.9
, pp. 826-836
-
-
Poirel, L.1
Nordmann, P.2
-
81
-
-
84937765381
-
Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: Mechanisms and epidemiology
-
Potron A, Poirel L, Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology. Int J Antimicrob Agents. 2015;45(6):568–585.
-
(2015)
Int J Antimicrob Agents
, vol.45
, Issue.6
, pp. 568-585
-
-
Potron, A.1
Poirel, L.2
Nordmann, P.3
-
82
-
-
34250861565
-
AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex
-
Ruzin A, Keeney D, Bradford PA. AdeABC multidrug efflux pump is associated with decreased susceptibility to tigecycline in Acinetobacter calcoaceticus–Acinetobacter baumannii complex. J Antimicrob Chemother. 2007;59(5):1001–1004.
-
(2007)
J Antimicrob Chemother
, vol.59
, Issue.5
, pp. 1001-1004
-
-
Ruzin, A.1
Keeney, D.2
Bradford, P.A.3
-
83
-
-
33747625237
-
Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
-
Bonomo RA, Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis. 2006;43(Suppl 2):S49–S56.
-
(2006)
Clin Infect Dis
, vol.43
, pp. S49-S56
-
-
Bonomo, R.A.1
Szabo, D.2
-
84
-
-
70349136689
-
Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system
-
Adams MD, Nickel GC, Bajaksouzian S, et al. Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system. Antimicrob Agents Chemother. 2009;53(9): 3628–3634.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, Issue.9
, pp. 3628-3634
-
-
Adams, M.D.1
Nickel, G.C.2
Bajaksouzian, S.3
-
85
-
-
78649650250
-
Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production
-
Moffatt JH, Harper M, Harrison P, et al. Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production. Antimicrob Agents Chemother. 2010;54(12):4971–4977.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.12
, pp. 4971-4977
-
-
Moffatt, J.H.1
Harper, M.2
Harrison, P.3
-
86
-
-
84857594163
-
Novel therapeutic strategies to counter Pseudomonas aeruginosa infections
-
Fothergill JL, Winstanley C, James CE. Novel therapeutic strategies to counter Pseudomonas aeruginosa infections. Expert Rev Anti Infect Ther. 2012;10(2):219–235.
-
(2012)
Expert Rev Anti Infect Ther
, vol.10
, Issue.2
, pp. 219-235
-
-
Fothergill, J.L.1
Winstanley, C.2
James, C.E.3
-
87
-
-
0014564064
-
Resistance of Pseudomonas to quaternary ammonium compounds. I. Growth in benzalkonium chloride solution
-
Adair FW, Geftic SG, Gelzer J. Resistance of Pseudomonas to quaternary ammonium compounds. I. Growth in benzalkonium chloride solution. Appl Microbiol. 1969;18(3):299–302.
-
(1969)
Appl Microbiol
, vol.18
, Issue.3
, pp. 299-302
-
-
Adair, F.W.1
Geftic, S.G.2
Gelzer, J.3
-
88
-
-
33747179934
-
The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter
-
Livermore DM, Woodford N. The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006;14(9):413–420.
-
(2006)
Trends Microbiol
, vol.14
, Issue.9
, pp. 413-420
-
-
Livermore, D.M.1
Woodford, N.2
-
89
-
-
0342762055
-
Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: A nationwide multicenter study
-
Vahaboglu H, Oztürk R, Aygün G, et al. Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother. 1997; 41(10):2265–2269.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, Issue.10
, pp. 2265-2269
-
-
Vahaboglu, H.1
Oztürk, R.2
Aygün, G.3
-
90
-
-
0032587031
-
Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate
-
Lauretti L, Riccio ML, Mazzariol A, et al. Cloning and characterization of blaVIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother. 1999;43(7):1584–1590.
-
(1999)
Antimicrob Agents Chemother
, vol.43
, Issue.7
, pp. 1584-1590
-
-
Lauretti, L.1
Riccio, M.L.2
Mazzariol, A.3
-
91
-
-
1642543088
-
Molecular analysis of metallo-β-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil
-
Poirel L, Magalhaes M, Lopes M, Nordmann P. Molecular analysis of metallo-β-lactamase gene bla(SPM-1)-surrounding sequences from disseminated Pseudomonas aeruginosa isolates in Recife, Brazil. Antimicrob Agents Chemother. 2004;48(4):1406–1409.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, Issue.4
, pp. 1406-1409
-
-
Poirel, L.1
Magalhaes, M.2
Lopes, M.3
Nordmann, P.4
-
93
-
-
2542479978
-
Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa
-
Girlich D, Naas T, Nordmann P. Biochemical characterization of the naturally occurring oxacillinase OXA-50 of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2004;48(6):2043–2048.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, Issue.6
, pp. 2043-2048
-
-
Girlich, D.1
Naas, T.2
Nordmann, P.3
-
94
-
-
73849084148
-
Diversity, epidemiology, and genetics of class D β-lactamases
-
Poirel L, Naas T, Nordmann P. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother. 2010;54(1):24–38.
-
(2010)
Antimicrob Agents Chemother
, vol.54
, Issue.1
, pp. 24-38
-
-
Poirel, L.1
Naas, T.2
Nordmann, P.3
-
95
-
-
0030815586
-
OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa
-
Philippon LN, Naas T, Bouthors AT, Barakett V, Nordmann P. OXA-18, a class D clavulanic acid-inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1997;41(10):2188–2195.
-
(1997)
Antimicrob Agents Chemother
, vol.41
, Issue.10
, pp. 2188-2195
-
-
Philippon, L.N.1
Naas, T.2
Bouthors, A.T.3
Barakett, V.4
Nordmann, P.5
-
96
-
-
69649087955
-
First detection of the OXA-40 carbapenemase in P. Aeruginosa isolates, located on a plasmid also found in A. Baumannii
-
Sevillano E, Gallego L, García-Lobo J. First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol (Paris). 2009;57(6):493–495.
-
(2009)
Pathol Biol (Paris)
, vol.57
, Issue.6
, pp. 493-495
-
-
Sevillano, E.1
Gallego, L.2
García-Lobo, J.3
-
97
-
-
80052828141
-
OXA-198, an acquired carbapenem-hydrolyzing class D β-lactamase from Pseudomonas aeruginosa
-
El Garch F, Bogaerts P, Bebrone C, Galleni M, Glupczynski Y. OXA-198, an acquired carbapenem-hydrolyzing class D β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother. 2011;55(10):4828–4833.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, Issue.10
, pp. 4828-4833
-
-
El Garch, F.1
Bogaerts, P.2
Bebrone, C.3
Galleni, M.4
Glupczynski, Y.5
-
98
-
-
33847792158
-
Tigecycline: In-vitro performance as a predictor of clinical efficacy
-
Hawkey P, Finch R. Tigecycline: in-vitro performance as a predictor of clinical efficacy. Clin Microbiol Infect. 2007;13(4):354–362.
-
(2007)
Clin Microbiol Infect
, vol.13
, Issue.4
, pp. 354-362
-
-
Hawkey, P.1
Finch, R.2
-
99
-
-
35448972600
-
Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: A systematic review and meta-analysis
-
Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60(5):913–920.
-
(2007)
J Antimicrob Chemother
, vol.60
, Issue.5
, pp. 913-920
-
-
Schwaber, M.J.1
Carmeli, Y.2
-
100
-
-
77952745422
-
Carbapenem-resistant Klebsiella pneumoniae bacteremia: Factors correlated with clinical and microbiologic outcomes
-
Nguyen M, Eschenauer GA, Bryan M, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiologic outcomes. Diagn Microbiol Infect Dis. 2010;67(2):180–184.
-
(2010)
Diagn Microbiol Infect Dis
, vol.67
, Issue.2
, pp. 180-184
-
-
Nguyen, M.1
Eschenauer, G.A.2
Bryan, M.3
-
101
-
-
84858627056
-
Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: Superiority of combination antimicrobial regimens
-
Qureshi ZA, Paterson DL, Potoski BA, et al. Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens. Antimicrob Agents Chemother. 2012;56(4):2108–2113.
-
(2012)
Antimicrob Agents Chemother
, vol.56
, Issue.4
, pp. 2108-2113
-
-
Qureshi, Z.A.1
Paterson, D.L.2
Potoski, B.A.3
-
102
-
-
79960697003
-
Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems?
-
Daikos G, Markogiannakis A. Carbapenemase-producing Klebsiella pneumoniae: (when) might we still consider treating with carbapenems? Clin Microbiol Infect. 2011;17(8):1135–1141.
-
(2011)
Clin Microbiol Infect
, vol.17
, Issue.8
, pp. 1135-1141
-
-
Daikos, G.1
Markogiannakis, A.2
|